About Viroplazin

Viroplazin is a groundbreaking, broad-spectrum antiviral veterinary medicine developed by Biotecton Kft. It’s trusted by veterinarians worldwide for its efficacy in treating dogs, cats, and pigs, offering unparalleled virus protection without reported side effects for over eight years.

Our unique mechanism stimulates the production of hypothiocyanite (OSCN⁻), a powerful antiviral molecule, by enhancing the animal’s innate immune system. This innovative approach provides robust defense against a wide range of viruses.

In today’s world of rapidly mutating viruses, Viroplazin stands apart. Unlike conventional antivirals targeting specific enzymes, our product activates the body’s natural defense mechanisms through an innovative supramolecular complex. This formulation increases hypothiocyanite production, enhancing innate immunity and bypassing viral variability.

Viroplazin leverages the lactoperoxidase system of mucosal surfaces to maintain stable OSCN⁻ levels, providing sustained antiviral protection. This approach enhances the adaptive immune system without suppressing it, offering unmatched clinical response and safety.

• Non-Toxic Formulation: Safe at higher doses.
• Rapid Response: Symptom relief within 1–2 days.
• Prevention and Treatment: Effective in outbreaks.

Viroplazin is more than just an antiviral; it introduces a new therapeutic concept by fortifying the body’s first line of defense. This next-generation antiviral supports quick recovery and potential natural immunity development, akin to vaccination but without side effects.

In an age of pandemics and zoonotic threats, rapid, safe, and broad-spectrum antiviral solutions are essential. Viroplazin combines scientific rigor, natural defense, and clinical effectiveness, making it a vital addition to any emergency kit.